消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

COVID-19大流行期间的胃肠内镜临床和操作指导 2020

2020-10-22 Acta Med Indones . 2020 Oct;52(4):431-435.

胃肠内镜

世界卫生组织（WHO）已宣布COVID-19为全球大流行，因为确诊的SARS-C0V-2感染病例数，受影响的国家数和高死亡率都在不断增加。 全球COVID-19大流行还将影响卫生保健的各个方面，包括内

中文标题：

COVID-19大流行期间的胃肠内镜临床和操作指导 2020

英文标题：

A Clinical and Procedural Guideline for Gastrointestinal Endoscopy Units during COVID-19 Pandemic Era

发布机构：

发布日期：

2020-10-22

简要介绍：

世界卫生组织（WHO）已宣布COVID-19为全球大流行，因为确诊的SARS-C0V-2感染病例数，受影响的国家数和高死亡率都在不断增加。 全球COVID-19大流行还将影响卫生保健的各个方面，包括内窥镜服务。 印度尼西亚消化内镜协会（ISDE）为执行内窥镜检查程序的医生提供了范围，并制定了临床和程序指南，可为印度尼西亚进行胃肠内镜检查的医生提供参考。

相关资料下载：
[AttachmentFileName(sort=1, fileName=1651-6106-1-PB.pdf)] GetToolGuiderByIdResponse(projectId=1, id=818d11c0020593b6, title=COVID-19大流行期间的胃肠内镜临床和操作指导 2020, enTitle=A Clinical and Procedural Guideline for Gastrointestinal Endoscopy Units during COVID-19 Pandemic Era, guiderFrom=Acta Med Indones . 2020 Oct;52(4):431-435., authorId=0, author=, summary=世界卫生组织（WHO）已宣布COVID-19为全球大流行，因为确诊的SARS-C0V-2感染病例数，受影响的国家数和高死亡率都在不断增加。 全球COVID-19大流行还将影响卫生保健的各个方面，包括内, cover=, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Thu Oct 22 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p><span class="VIiyi" lang="zh-CN"><span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="0">世界卫生组织（WHO）已宣布COVID-19为全球大流行，因为确诊的SARS-C0V-2感染病例数，受影响的国家数和高死亡率都在不断增加。</span> <span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="1">全球COVID-19大流行还将影响卫生保健的各个方面，包括内窥镜服务。</span> <span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="2">印度尼西亚消化内镜协会（ISDE）为执行内窥镜检查程序的医生提供了范围，并制定了临床和程序指南，可为印度尼西亚进行胃肠内镜检查的医生提供参考。</span></span></p>, tagList=[TagDto(tagId=17990, tagName=胃肠内镜)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=76, categoryName=胃肠外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=20, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8925, appHits=98, showAppHits=0, pcHits=295, showPcHits=8827, likes=1, shares=37, comments=11, approvalStatus=1, publishedTime=Mon Feb 15 11:11:23 CST 2021, publishedTimeString=2020-10-22, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Sat Feb 13 21:06:35 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 12:42:32 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=1651-6106-1-PB.pdf)])
1651-6106-1-PB.pdf
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=949271, encodeId=ac469492e1e6, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Mar 18 15:50:03 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948873, encodeId=d3b59488e39a, content=不错哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Tue Mar 16 23:56:27 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947186, encodeId=5cc794e186bd, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Mar 10 18:08:18 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945445, encodeId=134094544535, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Mar 04 15:19:48 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944880, encodeId=c5739448802b, content=好指古南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Mar 02 18:57:21 CST 2021, time=2021-03-02, status=1, ipAttribution=)]
    2021-03-18 jyzxjiangqin

    好文章！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=949271, encodeId=ac469492e1e6, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Mar 18 15:50:03 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948873, encodeId=d3b59488e39a, content=不错哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Tue Mar 16 23:56:27 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947186, encodeId=5cc794e186bd, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Mar 10 18:08:18 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945445, encodeId=134094544535, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Mar 04 15:19:48 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944880, encodeId=c5739448802b, content=好指古南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Mar 02 18:57:21 CST 2021, time=2021-03-02, status=1, ipAttribution=)]
    2021-03-16 ms2000001748592435

    不错哦

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=949271, encodeId=ac469492e1e6, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Mar 18 15:50:03 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948873, encodeId=d3b59488e39a, content=不错哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Tue Mar 16 23:56:27 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947186, encodeId=5cc794e186bd, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Mar 10 18:08:18 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945445, encodeId=134094544535, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Mar 04 15:19:48 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944880, encodeId=c5739448802b, content=好指古南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Mar 02 18:57:21 CST 2021, time=2021-03-02, status=1, ipAttribution=)]
    2021-03-10 jyzxjiangqin

    好文章！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=949271, encodeId=ac469492e1e6, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Mar 18 15:50:03 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948873, encodeId=d3b59488e39a, content=不错哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Tue Mar 16 23:56:27 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947186, encodeId=5cc794e186bd, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Mar 10 18:08:18 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945445, encodeId=134094544535, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Mar 04 15:19:48 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944880, encodeId=c5739448802b, content=好指古南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Mar 02 18:57:21 CST 2021, time=2021-03-02, status=1, ipAttribution=)]
    2021-03-04 jyzxjiangqin

    好文章！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=949271, encodeId=ac469492e1e6, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Mar 18 15:50:03 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948873, encodeId=d3b59488e39a, content=不错哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Tue Mar 16 23:56:27 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947186, encodeId=5cc794e186bd, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Mar 10 18:08:18 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945445, encodeId=134094544535, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Mar 04 15:19:48 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944880, encodeId=c5739448802b, content=好指古南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Mar 02 18:57:21 CST 2021, time=2021-03-02, status=1, ipAttribution=)]
    2021-03-02 jyzxjiangqin

    好指古南！

    0

相关指南

2020 KSGE临床实践指南：胃肠内镜检查中抗栓药物的管理

韩国胃肠内镜学会(KSGE,Korean Society of Gastrointestinal Endoscopy) · 2020-11-26

2016 ESGE/ESPGHAN指南：儿童胃肠内镜检查

欧洲胃肠道内窥镜学会(ESGE,European Society of Gastrointestinal Endoscopy) · 2016-09-12